Mesoblast (MESO) Enterprise Value: 2015-2025
Historic Enterprise Value for Mesoblast (MESO) over the last 9 years, with Jun 2025 value amounting to $1.1 billion.
- Mesoblast's Enterprise Value rose 74.08% to $1.1 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $896.2 million, marking a year-over-year increase of 110.85%. This contributed to the annual value of $1.1 billion for FY2025, which is 74.08% up from last year.
- As of Q2 2025, Mesoblast's Enterprise Value stood at $1.1 billion, which was down 50.25% from $2.2 billion recorded in Q4 2024.
- Over the past 5 years, Mesoblast's Enterprise Value peaked at $2.2 billion during Q4 2024, and registered a low of $107.8 million during Q4 2023.
- For the 3-year period, Mesoblast's Enterprise Value averaged around $826.0 million, with its median value being $566.4 million (2023).
- In the last 5 years, Mesoblast's Enterprise Value tumbled by 72.57% in 2022 and then skyrocketed by 1,938.62% in 2024.
- Mesoblast's Enterprise Value (Quarterly) stood at $485.9 million in 2021, then declined by 24.21% to $368.2 million in 2022, then plummeted by 70.72% to $107.8 million in 2023, then skyrocketed by 1,938.62% to $2.2 billion in 2024, then surged by 74.08% to $1.1 billion in 2025.
- Its Enterprise Value stands at $1.1 billion for Q2 2025, versus $2.2 billion for Q4 2024 and $628.1 million for Q2 2024.